ZOE secures $15m from Coefficient Capital to fund US expansion
The investment round was led by New York-based Coefficient Capital with participation from multiple venture firms.
London-based personalised nutrition startup providing at-home testing and app-based dietary insights.
ZOE has secured $15m in funding led by Coefficient Capital to support its expansion into the United States. Additional backing came from investors including Accomplice, Balderton Capital, Daphni, Ahren, THVC and Steven Bartlett's Flight Fund.
The London-based personalised nutrition startup combines science, at-home testing and artificial intelligence to help members understand their metabolic health and improve gut microbiome function. The new capital will target US growth while maintaining engagement across its existing community of over 100,000 members worldwide.
From the founder
"I am really excited that Coefficient Capital has decided to join us in our mission to improve the health of millions,"
Jonathan Wolf
Cofounder and CEO at ZOE
Investor perspective
"The way ZOE combines their own science and data to drive huge shifts in consumer behavior towards health immediately impressed us"
Andrew Goletka
Managing Partner, Coefficient Capital
Use of funds
- 01Expand into international markets
Investors
Categories
About the company
ZOE
ZOE offers personalised nutrition programmes using advanced at-home testing and mobile applications.